-
Something wrong with this record ?
Valve cuspidity: a risk factor for aortic valve repair
T. Holubec, P. Zacek, M. Jamaliramin, MY. Emmert, M. Tuna, P. Nedbal, J. Dominik, J. Harrer, V. Falk, J. Vojacek,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
24919866
DOI
10.1111/jocs.12382
Knihovny.cz E-resources
- MeSH
- Aortic Valve abnormalities MeSH
- Aortic Valve Insufficiency surgery MeSH
- Time Factors MeSH
- Adult MeSH
- Cardiovascular Surgical Procedures MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Follow-Up Studies MeSH
- Heart Valve Diseases MeSH
- Recurrence MeSH
- Reoperation statistics & numerical data MeSH
- Retrospective Studies MeSH
- Risk Factors MeSH
- Aged MeSH
- Tricuspid Valve MeSH
- Age Factors MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: The aim of this study was to analyze short- and mid-term results after aortic valve (AV) repair with particular regard to the impact of valve cuspidity (bicuspid versus tricuspid aortic valve). METHODS: One hundred patients with aortic regurgitation (AR) undergoing aortic valve repair between November 2007 and October 2012 were included in the study. Sixty patients had bicuspid AV (BAV group; 11 females) and 40 patients had tricuspid AV (TAV group; 13 females). AR > grade 2 was present in 47 (78%) patients in the BAV and in 35 (88%) patients in the TAV group. Follow-up was complete in 100% and median was 25 months. RESULTS: Isolated aortic valve repair was performed in 27 (45%) of BAV patients and in six (15%) of TAV patients. Replacement of the ascending aorta and/or aortic root was performed in 33 (55%) of BAV patients and in 34 (86%) of TAV patients. There was no death within 30 days postoperatively, while two patients died (TAV group) during the follow-up period. There was no statistical difference between BAV and TAV groups with regard to the survival (100 ± 0% vs. 95 ± 4%, p = 0.102), the three-year freedom from AV-related reoperation (90 ± 5% vs. 89 ± 6%, p = 0.456), and the three-year freedom from AR grade > 2 (86 ± 6% vs. 82 ± 7%, p = 0.866), respectively. CONCLUSIONS: This study demonstrates no difference in mid-term results after regurgitant bicuspid and tricuspid aortic valve repair, suggesting that bicuspid valve may not be a risk factor for aortic valve repair.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15023338
- 003
- CZ-PrNML
- 005
- 20150724110013.0
- 007
- ta
- 008
- 150709s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jocs.12382 $2 doi
- 035 __
- $a (PubMed)24919866
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Holubec, Tomas $u Department of Cardiac Surgery, Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Division of Cardiovascular Surgery, University Hospital Zurich, Zurich, Switzerland.
- 245 10
- $a Valve cuspidity: a risk factor for aortic valve repair / $c T. Holubec, P. Zacek, M. Jamaliramin, MY. Emmert, M. Tuna, P. Nedbal, J. Dominik, J. Harrer, V. Falk, J. Vojacek,
- 520 9_
- $a BACKGROUND: The aim of this study was to analyze short- and mid-term results after aortic valve (AV) repair with particular regard to the impact of valve cuspidity (bicuspid versus tricuspid aortic valve). METHODS: One hundred patients with aortic regurgitation (AR) undergoing aortic valve repair between November 2007 and October 2012 were included in the study. Sixty patients had bicuspid AV (BAV group; 11 females) and 40 patients had tricuspid AV (TAV group; 13 females). AR > grade 2 was present in 47 (78%) patients in the BAV and in 35 (88%) patients in the TAV group. Follow-up was complete in 100% and median was 25 months. RESULTS: Isolated aortic valve repair was performed in 27 (45%) of BAV patients and in six (15%) of TAV patients. Replacement of the ascending aorta and/or aortic root was performed in 33 (55%) of BAV patients and in 34 (86%) of TAV patients. There was no death within 30 days postoperatively, while two patients died (TAV group) during the follow-up period. There was no statistical difference between BAV and TAV groups with regard to the survival (100 ± 0% vs. 95 ± 4%, p = 0.102), the three-year freedom from AV-related reoperation (90 ± 5% vs. 89 ± 6%, p = 0.456), and the three-year freedom from AR grade > 2 (86 ± 6% vs. 82 ± 7%, p = 0.866), respectively. CONCLUSIONS: This study demonstrates no difference in mid-term results after regurgitant bicuspid and tricuspid aortic valve repair, suggesting that bicuspid valve may not be a risk factor for aortic valve repair.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a aortální chlopeň $x abnormality $7 D001021
- 650 _2
- $a aortální insuficience $x chirurgie $7 D001022
- 650 _2
- $a kardiovaskulární chirurgické výkony $7 D013504
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a nemoci srdečních chlopní $7 D006349
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a reoperace $x statistika a číselné údaje $7 D012086
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a trikuspidální chlopeň $7 D014261
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zacek, Pavel
- 700 1_
- $a Jamaliramin, Mostafa
- 700 1_
- $a Emmert, Maxmilian Y
- 700 1_
- $a Tuna, Martin
- 700 1_
- $a Nedbal, Pavel
- 700 1_
- $a Dominik, Jan
- 700 1_
- $a Harrer, Jan
- 700 1_
- $a Falk, Volkmar
- 700 1_
- $a Vojacek, Jan
- 773 0_
- $w MED00002566 $t Journal of cardiac surgery $x 1540-8191 $g Roč. 29, č. 5 (2014), s. 585-92
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24919866 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20150724110053 $b ABA008
- 999 __
- $a ok $b bmc $g 1083676 $s 906331
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 29 $c 5 $d 585-92 $i 1540-8191 $m Journal of cardiac surgery $n J Card Surg $x MED00002566
- LZP __
- $a Pubmed-20150709